Effect of Prosopis Ointment in Dermatitis

Comparison of the Effect of Prosopis Ointment with Eucerin Emollient on Clinical Signs of Patients with Atopic Dermatitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190220042770N1

Enrollment

Registered

2019-03-09

Start date

2019-03-13

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis. Atopic dermatitis, unspecified

Interventions

Intervention 1: Intervention group: Prosopis ointment twice a day for 14 days. Intervention 2: Control group: Eucerin twice a day for 14 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Typical lesions of Mild to Moderate Atopic Dermatitis

Exclusion criteria

Exclusion criteria: Patients with Psoriasis Sensitivity to Ointment Concurrent Bacterial infection or Systemic disease (except Asthma and Allergic Rhinitis)

Design outcomes

Primary

Measure	Time frame
Eczema area and Severity index. Timepoint: Before starting treatment and ending weeks 1 and 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.	—

Secondary

Measure	Time frame
Erythema. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Tickness. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Scratching or Excoriation. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Lichenification. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.	—

Measure

Time frame

Erythema. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Tickness. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Scratching or Excoriation. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.;Lichenification. Timepoint: Before starting treatment and week 1, 3 and 6. Method of measurement: EASI Questionnaire for Atopic Dermatitis.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSayed Kamal Hosseinian Nodushan

Yazd University of Medical Sciences

sk.hosseinian@ssu.ac.ir+98 35 3733 0122

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026